Will MiMedx Group Inc. (NASDAQ:MDXG) Recover?


MiMedx Group, Inc. (NASDAQ:MDXG), a member of Medical Appliances & Equipment, has a market of $1.61B.

The company has seen its stock rally between a high and a low of $-6.95% and $106.48%, respectively, over the last 12 months.

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction. Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

Recently, MiMedx Group, Inc. (NASDAQ:MDXG) announced that it will attend the 14th Annual Craig-Hallum Institutional Investor Conference in Minneapolis, Minnesota. Parker H. “Pete” Petit, Chairman and CEO, Michael J. Senken, Chief Financial Officer, Christopher M. Cashman, EVP, Chief Commercialization Officer, and Mark Landy, VP, Strategic Initiatives, are scheduled to participate in one-on-one and small group meetings on Wednesday, May 31, 2017, at The Depot Renaissance Minneapolis Hotel.

The stock’s performance for the week is -5.91% and performance of the month is 24.39%. For the quarter, though, the stock has moved 70.39%, compared with 47.28% movement for the half-year period and 104.42% for the year. So far this year shares of MiMedx Group, Inc. have moved 61.74%.

Various analysts have weighed on the stock of MiMedx Group, Inc., giving it average price target of $13.67. That compares with the current price of $14.33. In terms of stock recommendation, the average analysts? recommendation on the stock is 2.30.

MiMedx Group, Inc. stock has average volume and relative volume of 1.48M and 0.63, respectively.

The weekly volatility measure for the stock of MiMedx Group, Inc. is 3.37%, while the monthly volatility measure stands at 5.28%.

The stock has a short float of 24.71% and short ratio of 17.13, which is a market sentiment indicator offering a hint on whether investors expect a stock to rise or fall.

MiMedx Group, Inc. has a current ratio of 2.50 for the most recent quarter. Quick ratio for the same period is 2.10. The company has Total/Debt/Equity ratio of Total Debt/Equity 0.00 and Long Term Debt/Equity ratio 0.00.

MiMedx Group, Inc. has produced return on equity of 11.90% for the last 12 months, while return on investment for the same period is 9.30%. It also generated return on assets of 8.20% for the trailing 12 months.

The company reported Price to Free Cash Flow for the trailing 12 months of 50.00.